Filed: Apr. 25, 2019
Latest Update: Apr. 25, 2019
Summary: JOINT MOTION FOR ONE-DAY EXTENSION OF DEADLINE TO SUBMIT JOINT STATUS REPORT MIRANDA M. DU , District Judge . Pursuant to the Court's April 17, 2019 Order (ECF No. 203), Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, "Amarin"), Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited (collectively, "Hikma") and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (collectively, "DRL") in the a
Summary: JOINT MOTION FOR ONE-DAY EXTENSION OF DEADLINE TO SUBMIT JOINT STATUS REPORT MIRANDA M. DU , District Judge . Pursuant to the Court's April 17, 2019 Order (ECF No. 203), Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, "Amarin"), Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited (collectively, "Hikma") and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (collectively, "DRL") in the ab..
More
JOINT MOTION FOR ONE-DAY EXTENSION OF DEADLINE TO SUBMIT JOINT STATUS REPORT
MIRANDA M. DU, District Judge.
Pursuant to the Court's April 17, 2019 Order (ECF No. 203), Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, "Amarin"), Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited (collectively, "Hikma") and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (collectively, "DRL") in the above-referenced consolidated action were required to submit a joint status report within seven days of the Court's Order. Since the Court's April 17, 2019 Order, the parties have diligently worked on the conditions under which the parties would be prepared to proceed with the currently scheduled January 13, 2020 trial. The parties are close to an agreement on these conditions, but request additional time to solidify the terms of this agreement. The parties therefore respectfully request a one-day extension—to Thursday, April 25, 2019—of the deadline to submit the Joint Status Report.
DATED: April 24, 2019 Respectfully submitted,
/s/Jason D. Smith /s/ Constance S. Huttner
Nicholas J. Santoro (Nev. Bar No. 532) Michael D. Rounds (Nev. Bar No. 4734)
Jason D. Smith (Nev. Bar No. 9691) Ryan J. Cudnik (Nev. Bar No. 12948)
SANTORO WHITMIRE, LTD. BROWNSTEIN HYATT FARBER
10100 W. Charleston Blvd., Suite 250 SCHRECK, LLP
Las Vegas, NV 89135 5371 Kietzke Lane
Tel: (702) 948-8771/Fax: (702) 948-8773 Reno, NV 89511
Email: nsantoro@santoronevada.com, Tel.: (775) 324-4100/Fax: (775) 333-8171
jsmith@santoronevada.com Email: mrounds@bhfs.com,
rcudnik@bhfs.com
Christopher N. Sipes (admitted pro hac vice)
Einar Stole (admitted pro hac vice) Constance S. Huttner (admitted pro hac vice)
Michael N. Kennedy (admitted pro hac vice) Frank D. Rodriguez (admitted pro hac vice)
Megan P. Keane (admitted pro hac vice) Caroline Sun (admitted pro hac vice)
Eric R. Sonnenschein (admitted pro hac vice) Beth Finkelstein (admitted pro hac vice)
Alaina M. Whitt (admitted pro hac vice) WINDELS MARX LANE &
Han Park (admitted pro hac vice) MITTENDORF, LLP
Jordan L. Moran (admitted pro hac vice) 1 Giralda Farms, Suite 100
COVINGTON & BURLING LLP Madison, NJ 07940
One CityCenter, 850 Tenth Street, NW Tel: (973) 966-3200/Fax: (973) 966-3250
Washington, DC 20001 Email: chuttner@windelsmarx.com,
Tel: (202) 662-6000/Fax: (202) 662-6291 frodriguez@windelsmarx.com,
Email: csipes@cov.com, estole@cov.com, csun@windelsmarx.com,
mkennedy@cov.com, mkeane@cov.com, bfinkelstein@windelsmarx.com
esonnenschein@cov.com, awhitt@cov.com,
hpark@cov.com, jmoran@cov.com Attorneys for Defendants Dr. Reddy's
Attorneys for Plaintiffs Amarin Pharma, Inc. Laboratories, Inc. and Dr. Reddy's
and Amarin Pharmaceuticals Ireland Laboratories, Ltd.
Limited
/s/Eimeric Reig-Plessis
Wayne A. Shaffer (Nev. Bar No. 1519)
LAXALT & NOMURA, LTD.
9790 Gateway Drive, Suite 200
Reno, NV 89521
Tel: (775) 322-1170
Email: wshaffer@laxalt-nomura.com
George C. Lombardi (admitted pro hac vice)
WINSTON & STRAWN LLP
35 W. Wacker Drive
Chicago, IL 60601
Tel: (312) 558-5969
Email: glombard@winston.com
Charles B. Klein (admitted pro hac vice)
Claire A. Fundakowski (admitted pro hac
vice)
WINSTON & STRAWN LLP
1700 K Street N.W.
Washington, D.C. 20006
Tel: (202) 282-5000
Email: cklein@winston.com,
cfundakowski@winston.com
Eimeric Reig-Plessis (admitted pro hac vice)
WINSTON & STRAWN LLP
101 California Street
San Francisco, CA 94111
Tel: (415) 591-6808
Email: ereigplessis@winston.com
Attorneys for Defendants Hikma
Pharmaceuticals USA Inc. and Hikma
Pharmaceuticals International Limited
